This firm fixed-price purchase order was awarded by the National Institutes of Health (NIH) to Miltenyi Biotec, Inc., a global biotechnology company that provides products and services to support biomedical research, cell therapy development, and clinical translation. The $41,814.00 award is for a GenTLEMACS Octo Dissociator with heaters, which will allow the Tissue Analysis Core (TAC) at the NIH's Vaccine Research Center (VRC) to perform tissue processing of lung, liver, or tumor tissues to create single-cell suspensions. This sole-source procurement was justified under the statutory authority of 41 U.S.C. 1901(e)(2), as implemented by FAR 13.106-1, as the NIH determined Miltenyi Biotec was the only responsible source that could satisfy the agency's requirements. The award is not associated with a larger indefinite delivery vehicle, and there was no set-aside designation.